Revance Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.0M | 119k | 8.79 |
| 2023-09-30 | $1.3M | 111k | 11.47 |
| 2023-06-30 | $2.9M | 91k | 32.21 |
| 2023-03-31 | $2.9M | 91k | 32.21 |
| 2022-12-31 | $1.5M | 79k | 18.46 |
| 2022-09-30 | $1.9M | 70k | 27.00 |
| 2022-06-30 | $951k | 69k | 13.82 |
| 2022-03-31 | $1.3M | 66k | 19.50 |
| 2021-12-31 | $1.1M | 66k | 16.32 |
| 2021-09-30 | $10M | 363k | 27.86 |
| 2021-06-30 | $11M | 370k | 29.64 |
| 2021-03-31 | $11M | 384k | 27.95 |
| 2020-12-31 | $11M | 375k | 28.34 |
| 2020-09-30 | $1.1M | 42k | 25.14 |
| 2020-06-30 | $1000k | 41k | 24.42 |
| 2020-03-31 | $519k | 35k | 14.80 |
| 2019-12-31 | $490k | 30k | 16.23 |
| 2019-09-30 | $183k | 14k | 13.00 |
| 2019-06-30 | $169k | 13k | 12.97 |
| 2019-03-31 | $205k | 13k | 15.76 |
| 2015-12-31 | $318k | 9.3k | 34.19 |
| 2015-09-30 | $259k | 8.7k | 29.77 |
| 2015-06-30 | $278k | 8.7k | 31.95 |
| 2014-12-31 | $1.1M | 65k | 16.93 |
| 2014-09-30 | $1.3M | 65k | 19.33 |
| 2014-06-30 | $2.2M | 65k | 34.00 |
| 2014-03-31 | $1.5M | 48k | 31.49 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas